RELATION OF ANTIPLATELET THERAPY DISCONTINUATION AFTER CORONARY STENTING WITH THE RISK OF ADVERSE CARDIOVASCULAR EVENTS

被引：0

作者：

Watanabe, Hirotoshi ^{[1
]}

Morimoto, Takeshi ^{[1
]}

Kimura, Takeshi ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期

关键词：

D O I：

10.1016/S0735-1097(14)61533-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

915-06

引用

页码：A1530 / A1530

页数：1

共 50 条

[41] Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting [J].

Eisen, Alon ;

Bhatt, Deepak L. .

HEART, 2017, 103 (11) :871-884

[42] Long term adherence to dual antiplatelet therapy and late adverse cardiovascular events [J].

Bra, Somiot S. ;

Chirumamilla, Amala ;

Mehran, Roxana ;

Syros, George ;

Singh, Varinder ;

Singh, Binoy ;

Taviloglu, Gurkan ;

Higginbotham, Laura ;

Stone, Gregg W. ;

Moses, Jeffrey W. ;

Leon, Martin B. ;

Dangas, George .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) :B88-B88

[43] Anxiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting [J].

Meyer, Thomas ;

Hussein, Sharif ;

Lange, Helmut W. ;

Herrmann-Lingen, Christoph .

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (01) :75-82

[44] High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome [J].

Cuisset, T ;

Frere, C ;

Quilici, J ;

Barbou, F ;

Morange, PE ;

Hovasse, T ;

Bonnet, JL ;

Alessi, MC .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (03) :542-549

[45] High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome [J].

Cuisset, T ;

Frere, C ;

Hovasse, T ;

Quilici, J ;

Barbou, F ;

Bonnet, JL ;

Alessi, MC .

CIRCULATION, 2005, 112 (17) :U676-U676

[46] Removal of an epidural catheter without discontinuation of dual antiplatelet therapy in a patient with postoperative urgent coronary stenting [J].

Tuncali, Bahattin ;

Boya, Hakan .

JOURNAL OF CLINICAL ANESTHESIA, 2016, 28 :83-84

[47] Liver transplant outcome of cirrhotic patients treated with coronary stenting and early discontinuation of dual antiplatelet therapy [J].

Saracco, M. ;

Lavezzo, B. ;

Tandoi, F. ;

Calleri, A. ;

Manuli, C. ;

Giorgi, M. ;

Panio, A. ;

Ottobrelli, A. ;

Balagna, R. ;

Romagnoli, R. ;

Martini, S. .

DIGESTIVE AND LIVER DISEASE, 2023, 55 :S28-S28

[48] Patterns and Outcomes of Dual Antiplatelet Therapy Discontinuation After Percutaneous Coronary Intervention [J].

Franchi, Francesco ;

Rollini, Fabiana .

JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (08) :807-809

[49] Invasiveness of previous treatment for peripheral arterial disease and risk of adverse cardiac events after coronary stenting [J].

Pinxterhuis, Tineke H. ;

von Birgelen, Clemens ;

Geelkerken, Robert H. ;

Doggen, Carine J. M. ;

Menting, Theo P. ;

van Houwelingen, K. Gert ;

Linssen, Gerard C. M. ;

Ploumen, Eline H. .

CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2024, 39 (02) :173-182

[50] Invasiveness of previous treatment for peripheral arterial disease and risk of adverse cardiac events after coronary stenting [J].

Tineke H. Pinxterhuis ;

Clemens von Birgelen ;

Robert H. Geelkerken ;

Carine J. M. Doggen ;

Theo P. Menting ;

K. Gert van Houwelingen ;

Gerard C. M. Linssen ;

Eline H. Ploumen .

Cardiovascular Intervention and Therapeutics, 2024, 39 :173-182

← 1 2 3 4 5 →